RNU7-170P

Across TCGA pan-cancer cohorts, RNU7-170P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU7-170P’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RNU7-170P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-170P is over-expressed in tumor.

LUAD, CHOL, and BRCA are the cancer types where RNU7-170P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-170P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.436	.004	5	view →
CHOL	All	II,III,IV	+1.745	<.001	4	view →
BRCA	Female	II,III,IV	+0.353	.001	4	view →
KIRC	Male	II,III,IV	+0.226	.024	2	view →
LUSC	Male	All	+0.299	.043	1	view →
BLCA	All	III,IV	+0.297	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RNU7-170P–LUAD

Open the LUAD breakdown →